Close Menu

NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Monday that its revenues for the first quarter of fiscal year 2019 fell 21 percent year over year.

For the three months ended Oct. 31, the firm reported total revenues of $21.3 million, down from $26.9 million in Q1 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.